Omnicell Inc. (OMCL) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Omnicell Inc. (OMCL:NASDAQ), powered by AI.

Current Price
$39.90
P/E Ratio
893.8
Market Cap
1.8B
Sector
Healthcare
What is the Omnicell Inc. stock price forecast?

Omnicell Inc. is currently trading at $39.90. View real-time AI analysis on Alpha Lenz.

What is Omnicell Inc. insider trading activity?

View the latest insider trading data for Omnicell Inc. on Alpha Lenz.

What is Omnicell Inc.'s P/E ratio?

Omnicell Inc.'s P/E ratio is 893.8.

Omnicell Inc.

NASDAQ · OMCL
$39.90-0.09(-0.23%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Omnicell Inc.'s future dividend policy...
Alpha Chat Insight

Omnicell Inc. trades at a P/E of 893.8 (premium valuation) with modest ROE of 0.2%.

Ask for details

Company Overview

Omnicell Inc. operates as a provider of medication management solutions and adherence tools within the healthcare industry. Its primary function is to optimize medication management and supply chain processes in healthcare facilities, aiming to enhance safety and efficiency. The company offers automated dispensing systems, pharmacy automation equipment, and software solutions tailored for acute care hospitals, long-term care settings, and other healthcare facilities. Notable features of Omnicell’s offerings include their ability to reduce medication errors, improve workflow efficiency, and facilitate better inventory management. Omnicell plays a significant role in the healthcare sector, impacting hospitals' and pharmacies' ability to comply with stringent regulatory standards while maintaining high levels of patient care. By integrating advanced technologies such as robotics, analytics, and cloud-based solutions, Omnicell supports the digital transformation of medication management, addressing challenges associated with manual processes and medication non-adherence. The company’s market significance is evident as it continually adapts to the evolving needs of healthcare providers, ensuring effective medication administration and promoting patient safety on a global scale.

CEOMr. Randall A. Lipps
SectorHealthcare
IndustryHealth Information Services
Employees3,650

Company Statistics

FY 2025

Profile

$1.83BMarket Cap
$1.18BRevenue
0.00Shares Out
3,650Employees

Margins

42.49%Gross
7.75%EBITDA
0.44%Operating
0.96%Pre-Tax
0.17%Net

Valuation

893.76P/E
1.49P/B
1.55EV/Sales
20.06EV/EBITDA
26.44P/FCF

Growth (CAGR)

-2.94%Rev 3Yr
5.84%Rev 5Yr
N/AOp Inc 3Yr
-32.01%Op Inc 5Yr
-28.64%Net Inc 3Yr
-42.34%Net Inc 5Yr

Returns

0.10%ROA
0.17%ROE
0.25%ROIC

Financial Health

$196.52MCash & Cash Equivalents
$546.39MNet Debt
60.31%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Omnicell Inc. (ticker: OMCL) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 3,650 employees. Market cap is $1.8B.

The current price is $39.9 with a P/E ratio of 893.76x and P/B of 1.49x.

ROE is 0.17% and operating margin is 0.44%. Annual revenue is $1.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Omnicell Inc. (OMCL) Stock Forecast 2026 $39.90 — Price, Financials & Analyst Targets | Alpha Lenz